These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
251 related items for PubMed ID: 10548188
21. Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: a multicenter, randomized, placebo-controlled, single-blind, dose escalation study. Abraham E, Reinhart K, Svoboda P, Seibert A, Olthoff D, Dal Nogare A, Postier R, Hempelmann G, Butler T, Martin E, Zwingelstein C, Percell S, Shu V, Leighton A, Creasey AA. Crit Care Med; 2001 Nov; 29(11):2081-9. PubMed ID: 11700399 [Abstract] [Full Text] [Related]
22. [Significance of serum procalcitonin levels in the evaluation of severity and prognosis of patients with systemic inflammatory response syndrome]. Huang WP, Jiang WQ, Hu B, Ye H, Zeng HK. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 May; 24(5):294-7. PubMed ID: 22587926 [Abstract] [Full Text] [Related]
23. Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory mediators. Orfanos SE, Kotanidou A, Glynos C, Athanasiou C, Tsigkos S, Dimopoulou I, Sotiropoulou C, Zakynthinos S, Armaganidis A, Papapetropoulos A, Roussos C. Crit Care Med; 2007 Jan; 35(1):199-206. PubMed ID: 17110873 [Abstract] [Full Text] [Related]
24. Impact of continuous hemofiltration on cytokines and cytokine inhibitors in oliguric patients suffering from systemic inflammatory response syndrome. van Bommel EF, Hesse CJ, Jutte NH, Zietse R, Bruining HA, Weimar W. Ren Fail; 1997 May; 19(3):443-54. PubMed ID: 9154661 [Abstract] [Full Text] [Related]
25. [Effect of vitamin D3 on the severity and prognosis of patients with sepsis: a prospective randomized double-blind placebo study]. Ding F, Zang B, Fu J, Ji K. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Feb; 29(2):106-110. PubMed ID: 28625255 [Abstract] [Full Text] [Related]
26. Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: a randomized, double-blind, placebo-controlled, multicenter clinical trial. BN 52021 Sepsis Study Group. Dhainaut JF, Tenaillon A, Le Tulzo Y, Schlemmer B, Solet JP, Wolff M, Holzapfel L, Zeni F, Dreyfuss D, Mira JP. Crit Care Med; 1994 Nov; 22(11):1720-8. PubMed ID: 7956274 [Abstract] [Full Text] [Related]
27. Comparison of procalcitonin and C-reactive protein as markers of sepsis. Luzzani A, Polati E, Dorizzi R, Rungatscher A, Pavan R, Merlini A. Crit Care Med; 2003 Jun; 31(6):1737-41. PubMed ID: 12794413 [Abstract] [Full Text] [Related]
28. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. Brun-Buisson C, Doyon F, Carlet J, Dellamonica P, Gouin F, Lepoutre A, Mercier JC, Offenstadt G, Régnier B. JAMA; 1995 Sep 27; 274(12):968-74. PubMed ID: 7674528 [Abstract] [Full Text] [Related]
30. Blood and plasma treatments: high-volume hemofiltration--a global view. Honoré PM, Joannes-Boyau O, Gressens B. Contrib Nephrol; 2007 Sep 27; 156():371-86. PubMed ID: 17464148 [Abstract] [Full Text] [Related]
31. [A new score system for prediction of death in patients with severe trauma: the value of death warning score]. Xueyuan L, Yu S, Min G, Ya X, He J, Miao C, Huaping L, Tao C. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Nov 27; 27(11):890-4. PubMed ID: 27132455 [Abstract] [Full Text] [Related]
40. Inflammatory mediators in relation to the development of multiple organ failure in patients after severe blunt trauma. Roumen RM, Redl H, Schlag G, Zilow G, Sandtner W, Koller W, Hendriks T, Goris RJ. Crit Care Med; 1995 Mar 27; 23(3):474-80. PubMed ID: 7874897 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]